Continuation and maintenance treatments for depression in older people

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 9, 2016, Pages

  Wilkinson, Philip ^a,b   Izmeth, Zehanah ^c  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

BECK DEPRESSION INVENTORY; DEPRESSION; FOLLOW UP; GERIATRIC MENTAL STATE; HAMILTON DEPRESSION RATING SCALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAINTENANCE THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; RESEARCH DIAGNOSTIC CRITERIA; REVIEW; SENESCENCE; SYSTEMATIC REVIEW;

EID: 84986540339     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006727.pub3     Document Type: Review

References (71)

1. Alexopoulos GS, Barnett SM, Young RC, Kalayam B, Kakuma T, Gabrielle M, et al. Executive dysfunction and long-term outcomes of geriatric depression. Archives of General Psychiatry 2000;57:285-90.
2. Dolberg O, Lonn LS, Kvist K. Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion 2014;30(7):1301-7. [10.1185/03007995.2014.904770]
3. Gorwood P, Weiller E, Lemming O, Katona C. Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry 2007;15(7):581-93.
4. Lyketsos CG, Weiller E, Katona C, Gorwood P. Are old-old patients with major depression more likely to relapse than young-old patients during continuation treatment with escitalopram?. BMC Geriatrics 2011;11:2.
5. Bent-Hansen J, Lunde M, Klysner R, Andersen M, Tanghoj P, Solstad K, et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry 2003;36(6):313-6.
6. Klysner R, Bent-Hansen J, Hansen HL, Lunde M, Pleidrup E, Poulsen DL, et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. British Journal of Psychiatry 2002;181:29-35.
7. Klysner R, Pledrup E, Hansen HL, Loldrup Poulsen D, Hansen JB, Lunde M, et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23-26; San Francisco, CA. 2001.
8. Klysner R, Pleidrup E, Hansen HL, Bent-Hansen J, Loldrup PD, Lunde M, et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology 2000;3(Suppl 3):211.
9. Klysner R, Pleidrup E, Hansen HL, Bent-Hansen J, Loldrup Poulsen D, Hopfner Petersen HE. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13-18; Chicago, IL. 2000:NR472.
10. Old Age Depression Interest Group. How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry 1993;162:175-82.
11. Dew MA, Reynolds CF 3rd, Mulsant B, Frank E, Houck PR, Mazumdar S, et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders 2001;65(2):155-66.
12. Lenze EJ, Dew MA, Mazumdar S, Begley AE, Cornes C, Miller MD, et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late-life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23-26; San Francisco. 2001.
13. Miller MD, Frank E, Cornes C, Houck PR, Reynolds CF 3rd. The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry 2003;11(1):97-102.
14. Reynolds CF 3rd, Frank E, Dew MA, Houck PR, Miller M, Mazumdar S, et al. Treatment of 70(+)-year-olds with recurrent major depression. Excellent short-term but brittle long-term response. American Journal of Geriatric Psychiatry 1999;7(1):64-9.
15. Reynolds CF III, Frank E, Perel JM, Imber SD, Cornes C, Miller MD, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA 1999;281(1):39-45.
16. Wilkinson P, Alder N, Juszczak E, Matthews H, Merritt C, Montgomery H, et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry 2009;24:68-75.
17. Abou-Saleh M, Abou-Saleh MT, Wilson K. Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24-29; Yokohama, Japan. 2002.
18. Wilson KCM, Mottram PG, Ashworth L, Abou-Saleh MT. Older community residents with depression: long-term treatment with sertraline. British Journal of Psychiatry 2003;182:492-7.
19. Reynolds CF III, Perel JM, Frank E, Cornes C, Miller MD, Houck PR, et al. Three-year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levels. American Journal of Psychiatry 1999;156(8):1177-81.
20. Carreira K, Miller MD, Frank E, Houck PR, Morse JQ, Dew MA, et al. A controlled evaluation of monthly maintenance Interpersonal psychotherapy in late-life depression with varying levels of cognitive function. International Journal of Geriatric Psychiatry 2008;23:1110-3.
21. Dombrovski AY, Lenze EJ, Dew MA, Mulsant BH, Pollock BG, Houck PR, et al. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. Journal of the American Geriatrics Society 2007;55(9):1325-32.
22. Reynolds CF, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, et al. Maintenance treatment of major depression in old age. New England Journal of Medicine 2006;354:1130-8.
23. Abou-Saleh MT, Katona C. Pharmacological treatment of depression. In: Abou-Saleh MT, Katona C editor(s). Principles and Practice of Geriatric Psychiatry. 3rd Edition. Chichester: Wiley, 2010:537-42.
24. American Psychiatric Association (APA). Diagnostic and Statistical Manual version IV. Washington, DC: American Psychiatric Association, 1994.
25. Areán PA, Alexopoulos GS. Psychosocial interventions for mental illness in late-life. International Journal of Geriatric Psychiatry 2007;22:99-100.
26. Beck AT, Steer RA, Brown GK. The Beck Depression Inventory. San Antonio, Texas: The Psychological Corporation, 1996.
27. Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. British Journal of Psychiatry 1997;171:328-34.
28. Blackburn I, James IA, Milne DL, Baker C, Standart S, Garland A, et al. The Revised Cognitive Therapy Scale (CTS-R): psychometric properties. Behavioural and Cognitive Psychotherapy 2001;29:431-46.
29. Blazer D. Psychiatry and the oldest old. American Journal of Psychiatry 2000;157:1915-24.
30. Cole MG, Bellevance F. The prognosis of depression in old age. American Journal of Geriatric Psychiatry 1997;5:4-14.
31. Copeland JRM, Kelleher MJ, Kellett JM, Gourlay AJ, Gurland BJ, Fleiss JL, et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. Development and reliability. Psychological Medicine 1976;6(3):439-49.
32. Evans O, Singleton N, Meltzer H, Stewart R, Pince M. The mental health of older people. The mental health of older people. London: HMSO, 2003.
33. Feighner JP, Robins E, Guze SB, Woodruff RA Jr, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 1972;26(1):57-63.
34. Forster E, Jones L, Saxton JM, Flower DJ, Foulds G, Powers HJ, et al. Recruiting older people to a randomised controlled dietary intervention trial - how hard can it be?. BMC Medical Research Methodology 2010;10:17. [DOI: 10.1186/1471-2288-10-17]
35. Frank E, Prien R, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Archives of General Psychiatry 1991;48:851-5.
36. Frederick JT, Steinman LE, Prohaska T, Satariano WA, Bruce M, Bryant L, et al for the Late Life Depression Special Interest Project Panelists. Community-based treatment of late life depression. An expert panel-informed literature review. American Journal of Preventive Medicine 2007;33(3):222-49.
37. Gansler DA, Suvak M, Arean P, Alexopoulos GS. Role of executive dysfunction and dysexecutive behaviour in late-life depression and disability. American Journal of Geriatric Psychiatry 2015;23(10):1038-45.
38. Garner J. Psychological treatments: psychodynamic psychotherapy. Oxford Textbook of Old Age Psychiatry. Oxford: OUP, 2008:275-83.
39. Geddes J, Carney S, Davies C, Furukawa T, Kupfer D, Frank E, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361:653-61.
40. Georgotas A, McCue RE, Cooper TB. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Archives of General Psychiatry 1989;46:783-6.
41. McMaster University. GRADEpro. McMaster University, 2014.
42. Guy W. Clinical Global Impressions: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health, 1976.
43. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960;23:56-62.
44. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
45. Katona CL, Livingstone G. How well do antidepressants work in older people: a systematic review of number needed to treat. Journal of Affective Disorders 2002;69:47-52.
46. Kok RM, Heeren TJ, Nolen WA. Continuing treatment of depression in the elderly: a systematic review and meta-analysis of double-blinded randomized controlled trials with antidepressants. American Journal of Geriatric Psychiatry 2011;19(3):249-55.
47. Korsnes MS, Ulstein ID. Cognitive effects of late life depression: review of neuropsychological findings. Journal of Behavioral and Brain Science 2015;4:141-57.
48. Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, et al. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet 2015;386 (9988):63-73.
49. Lenze EJ, Schulz R, Martire LM, Zdaniuk B, Glass T, Kop WJ, et al. The course of functional decline in older people with persistently elevated depressive symptoms: longitudinal survey from the Cardiovascular Health Study. Journal of the American Geriatrics Society 2005;53(4):569.
50. Luborsky L. Clinician's judgments of mental health. Archives of General Psychiatry 1962;7:407-17.
51. Michiels S, Piedbois P, Burdett S. Meta-analysis when only the median survival times are known: a comparison with individual patient data results. International Journal of Technology Assessment in Health Care 2005;21(1):119-25.
52. Miller MD, Frank E, Cornes C, Houck PR, Reynolds CF 3rd. The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry 2003;11(1):97-102.
53. Montgomery S, Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382-9.
54. Montgomery SA, Montgomery DB. Prophylactic treatment in recurrent unipolar depression. In: Montgomery S, Rouillon F editor(s). Long-term Treatment of Depression. Chichester: Wiley, 1992:53-79.
55. Mottram PG, Wilson K, Strobl JJ. Antidepressants for depressed elderly. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD003491.pub2]
56. National Institute for Health and Care Excellence. The treatment and management of depression in adults (updated version). National Clinical Practice Guideline 90, 2010. www.nice.org.uk/Guidance/cg90 (accessed 8 August 2016).
57. Paykel E, Scott J, Cornwall P, Abbott R, Crane C, Pope M, et al. Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. Psychological Medicine 2005;35:59-68.
58. Percudani MBC, Fortino I, Petrovich L. Antidepressant drug prescribing among elderly subjects: a population-based study. International Journal of Geriatric Psychiatry 2005;20:113-8.
59. The Nordic Cochrane Centre. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Cochrane Collaboration, 2014.
60. Reynolds CF 3rd, Butters MA, Lopez O, Pollock BG, Dew MA, Mulsant BH, et al. Maintenance treatment of depression in old age. A randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Archives of General Psychiatry 2011;68(1):51-60.
61. Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based Cognitive Therapy for Depression: a New Approach to Preventing Relapse. New York: Guilford Press, 2002.
62. Serfaty M, Haworth D, Blanchard M, Buszewicz M, Murad S, King M. Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care. Archives of General Psychiatry 2009;66(12):1332-40.
63. Valkanova V, Ebmeier KP. Vascular risk factors and depression in later life: a systematic review and meta-analysis. Biological Psychiatry 2013;73:406-13.
64. Wagner EF, Frank E, Steiner SC. Discriminating maintenance treatments for recurrent depression: development and implementation of a rating scale. Journal of Psychotherapy Practice and Research 1992;22:281-91.
65. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Centre, 1993.
66. World Health Organization. International Classification of Diseases, 10th Revision. Geneva: World Health Organization, 1992.
67. World Health Organization. World Report on Ageing and Health, 2015. Geneva: World Health Organization.
68. Wilkinson P. Psychotherapy of depression and dysthymia. Principles and Practice of Geriatric Psychiatry. 3rd Edition. Chichester: Wiley, 2010:543-51.
69. Wilson K, Mottram PG, Vassilas C. Psychotherapeutic treatments for older depressed people. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD004853.pub2]
70. Zarit SH, Zarit JM. Mental Disorders in Older Adults. New York: Guilford, 1998.
71. Wilkinson P, Izmeth Z. Continuation and maintenance treatments for depression in older people. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD006727.pub2]